30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Current & Critical

Capitalize on These Opportunities in the Emerging Outpatient Surgery Market

In this fourth installment of his quarterly column, Patrick Vega of Vizient Advisory Solutions provides a description of ambulatory settings and strategies, and suggests ways that device companies can capitalize on the shift from inpatient surgical settings to hospital outpatient departments, ASCs and outpatient sites of care.

Contributors to this article hypothesize that device companies that better understand the outpatient setting can more effectively adapt their products, services and support to meet customer needs.

Surgeon Insight: The Future of the Anterior Approach in Hip Replacement

DePuy Synthes announced the Anterior Advantage Matta Method in 1Q19. The namesake of the program, Joel Matta, M.D., is a surgeon at The Steadman Clinic, Co-founder and Chairman of the Anterior Hip Foundation and a pioneer of the anterior approach.

He began using the anterior approach in the late ‘90s and has remained dedicated to the technique, noting that it results in tissue preservation and shorter recovery time. More than two decades later, he remains committed to teaching and advancing the anterior approach. 

M&A Recap: Three 2Q Announcements in Spine

Of the 20 OEM-related M&A announcements we’ve covered in 2019 thus far, seven have related to the spine market. Of those, three were announced in rapid succession within this quarter. Let’s see who bought whom, and what they got: Medtronic/Titan Spine, Boston Scientific/Vertiflex and WishBone Medical/CSpine.

4 Orthopedic Robotic and Surgical Tracking Companies to Watch

The proliferation of computer-assisted technology companies entering the joint replacement, spine and trauma markets indicates to us that industry believes there's room for product introduction and adoption in robotic- and navigation-based surgery. Here we highlight four of these companies—three new, one established but newly-restructured—and their very different intraoperative technologies.

Burst of M&A Activity at the Close of 1Q19

As was shown last week at AAOS, companies are taking strides to connect their devices with technologies that support improved patient outcomes. That connection can come in the form of M&A activity—which certainly applies to transactions announced over the month of March in joint replacement.

Page Navigation
First